|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.153 -0.010 (-6.135%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2022/03 HKD(K$) | |
| Turnover | 136,635 | -12.454% | 329,937 | 532,089 | 410,021 | 509,955 |
| Cost of Sales | (80,051) | -0.221% | (177,913) | (276,557) | (221,380) | (268,732) |
| Gross Profit | 56,584 | -25.395% | 152,024 | 255,532 | 188,641 | 241,223 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2022/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (33,926) | 34.627% | (54,340) | (25,694) | (47,890) | (28,018) | |
| Taxation | 425 | -- | (7,074) | 689 | 3,647 | 6,343 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 264 | -- | 43 | 850 | 3,266 | 1,904 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (33,237) | 22.033% | (61,371) | (24,155) | (40,977) | (19,771) | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2022/03 HKD(K$) | |
| Net Finance Costs / (Income) | 1,826 | -24.949% | 3,754 | 1,914 | 1,785 | (1,578) |
| Depreciation & Amortisation | 18,883 | 1.686% | 38,232 | 36,407 | 37,687 | 22,149 |
| Directors' Emoluments | -- | -- | 420 | 421 | 315 | 449 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2022/03 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Disclaimer | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2022/03 | |
| EPS (cts) | -1.550 | 22.047% | -2.850 | -1.120 | -1.910 | -0.920 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.260 | 0.260 | 0.820 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.005) | (0.023) | 0.036 | (0.004) |
| NBV per share ($) | 0.226 | -- | 0.235 | 0.275 | 0.292 | 0.352 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -33,237 |
| %Change | 22.033% |
| EPS / (LPS) | HKD -0.016 |
| NBV Per Share ($) | HKD 0.226 |